Compare ACCL & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACCL | TELA |
|---|---|---|
| Founded | 2009 | 2012 |
| Country | Hong Kong | United States |
| Employees | 22 | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2M | 36.7M |
| IPO Year | N/A | 2019 |
| Metric | ACCL | TELA |
|---|---|---|
| Price | $1.64 | $0.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.31 |
| AVG Volume (30 Days) | ★ 72.0K | 63.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.80 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,300,000.00 |
| Revenue This Year | N/A | $18.41 |
| Revenue Next Year | N/A | $15.20 |
| P/E Ratio | $17.13 | ★ N/A |
| Revenue Growth | N/A | ★ 18.56 |
| 52 Week Low | $1.23 | $0.67 |
| 52 Week High | $5.00 | $2.48 |
| Indicator | ACCL | TELA |
|---|---|---|
| Relative Strength Index (RSI) | 45.64 | 48.78 |
| Support Level | $1.30 | $0.67 |
| Resistance Level | $1.69 | $0.93 |
| Average True Range (ATR) | 0.13 | 0.09 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 43.63 | 70.90 |
Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.